Biotechnology & Drugs
Emcure Pharmaceuticals
₹1,850
-0.51% (delayed)
NSE
Market Cap
₹0.35L Cr
52W High
₹2,047.4
52W Low
₹1,260.1
Volatility
33.91%
Key Metrics
P/E (TTM)
34.41
P/B
7.16
ROE (5Y avg)
21.28%
Debt/Equity
—
Op. Margin
14.44%
Net Margin
10.52%
Rev Growth 5Y
8.73%
Div Yield
0.19%
Sector P/E: 37.15
Financials (₹ Cr)
| Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 9,204 | 7,896 | 6,658 | 5,986 | 5,855 | 6,056 | 5,049 |
| Cost of Revenue | 3,657 | 3,285 | 2,595 | 2,369 | 2,330 | 2,627 | 2,130 |
| Gross Profit | 5,546 | 4,611 | 4,063 | 3,617 | 3,525 | 3,430 | 2,918 |
| Operating Income | 1,300 | 1,074 | 907 | 915 | 1,085 | 820 | 284 |
| Net Income Before Tax | 1,287 | 971 | 727 | 747 | 973 | 657 | 105 |
| Tax | 346 | 264 | 200 | 185 | 270 | 239 | 5 |
| Net Income | 924 | 681 | 498 | 532 | 662 | 392 | 84 |
| Diluted EPS | 48.77 | 36.43 | 26.35 | 28.13 | 35.02 | 20.74 | 4.42 |
INFORMATIONAL PURPOSES ONLY. NOT INVESTMENT ADVICE. DATA MAY BE DELAYED OR CONTAIN INACCURACIES. CONSULT A SEBI-REGISTERED ADVISER BEFORE INVESTING.